GlassScriptPhysician profile
Joseph Marzano
NPI 1942259718
$4,795.26
in general payments reported to CMS, 2019-2025
14 companies · $665 in 2025
The $665 reported for 2025 was more than what 75% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $198 · 2021: $478 · 2022: $1,181 · 2023: $144 · 2024: $1,596 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,293 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,293.26 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,155.25 | 2020-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $773.74 | 2019-2025 | Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $737.81 | 2019-2025 | Abilify Asimtufii, Rexulti |
| Neurocrine Biosciences, INC. | $480.73 | 2021-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $445.38 | 2022-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Indivior INC. | $388.17 | 2019-2024 | Perseris |
| Alkermes, INC. | $273.77 | 2019-2025 | Aristada, Lybalvi, Aristada Initio |
| Lundbeck LLC | $176.68 | 2019-2024 | Abilify Asimtufii |
| Vanda Pharmaceuticals INC. | $121.48 | 2019-2024 | Fanapt, Hetlioz |
| Abbvie INC. | $74.01 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.42 | 2019-2025 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $48.77 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $31.79 | 2024 | Auvelity |
| Idorsia Pharmaceuticals US INC | $14.26 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Marzano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.